✦ LIBER ✦
897 PUBLICATION Combination therapy with bicalutamide 50 mg plus a luteinising hormone-releasing hormone agonist (LHRHa) is cost effective compared with an LHRHa alone in metastatic prostate cancer
- Book ID
- 118623473
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 138 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.